Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
ciprofloxacin
|
| gptkbp:approvalYear |
2005
|
| gptkbp:ATCCode |
J01MA02
|
| gptkbp:contraindication |
hypersensitivity to ciprofloxacin
|
| gptkbp:drugClass |
fluoroquinolone antibiotic
|
| gptkbp:form |
500 mg
extended-release tablet 1000 mg |
| gptkbp:halfLife |
4 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Proquin XR
|
| gptkbp:indication |
urinary tract infection
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Depomed,_Inc.
|
| gptkbp:mechanismOfAction |
inhibits bacterial DNA gyrase
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea dizziness headache |
| gptkbp:bfsParent |
gptkb:Ciprofloxacin
|
| gptkbp:bfsLayer |
5
|